GLAUKOS Corp 4

Director Aimee S. Weisner received an option award for 2,987 shares of Glaukos Corp common stock with a corrected exercise price of $106.52.

On May 28, 2026, Director Aimee S. Weisner received a grant of 2,987 stock options (right to buy common stock) of Glaukos Corp under the issuer’s Director Compensation Policy, with an exercise price of $106.52 and vesting in full on May 28, 2027, and expiring on May 28, 2036. This Form 4/A is an amendment to correct the originally misreported exercise price (previously shown as $53.57) and does not reflect a purchase or sale of already-owned shares. Based on the current stock price of approximately $134.65, the intrinsic value of the option grant is roughly $84,000, and the reporting person’s post‑grant derivative holdings total 2,987 options.

Filing Facts

CIK

1192448

Ticker

GKOS

Form

4

Source Type

fda

Accession

0001227308-26-000008

Alert Tier

5